(Total Views: 616)
Posted On: 09/11/2025 4:03:36 PM
Post# of 156891
Great summary, Kat—I share your excitement about the future of this amazing molecule!
That said, while the mouse data is very encouraging, it actually dates back to RP’s early days with the company and was first presented at NobelCon 2017, if I recall correctly. It highlights the critical role of CCR5 in metastasis, whether using maraviroc or leronlimab. Of course, we all know leronlimab stands apart—safer, without a black box warning, and as BP used to say, a much more “elegant molecule” in how it binds to CCR5 compared to maraviroc.
Onward and upward!
That said, while the mouse data is very encouraging, it actually dates back to RP’s early days with the company and was first presented at NobelCon 2017, if I recall correctly. It highlights the critical role of CCR5 in metastasis, whether using maraviroc or leronlimab. Of course, we all know leronlimab stands apart—safer, without a black box warning, and as BP used to say, a much more “elegant molecule” in how it binds to CCR5 compared to maraviroc.
Onward and upward!
(9)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
